球菌β-乳糖酶等离子体pbla的起源,进化和成功,以及对公共卫生的影响
Tabea A Elsener1, Ana Cehovin1, Connor Philp1
1Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom.
PLoS pathogens
|May 6, 2025
概括
尼塞利亚淋病中的β-乳酸酶等离子体 (pbla) 可能起源于Haemophilus ducreyi. 它的传播由另一种等离子体 (pConj) 促进,威胁到抗生素和Doxy-PEP治疗,导致耐药性淋病.
科学领域:
- 微生物学 微生物学
- 遗传学 是一个遗传学.
- 公共卫生 公共卫生
背景情况:
- 尼塞利亚淋病是性传播感染 (STIs) 的主要原因之一,也是显著的抗菌素耐药性 (AMR) 威胁.
- 像pbla和pConj这样的等离子体以前使青素和四环素疗法无效.
- 目前的预防策略,包括多西环素暴露后预防 (Doxy-PEP),受到这些耐药机制的破坏.
研究的目的:
- 为了研究Neisseria gonorrhoeae中的β-乳糖酶等离子体 (pbla) 的起源和进化轨迹.
- 了解等离子体结合 (pConj) 在pbla.的传播和共发生中的作用.
- 评估pbla进化对抗菌素耐药性和治疗策略的影响.
主要方法:
- 遗传学分析以追踪pbla等离子体的起源.
- 比较基因组学以确定pbla变体的进化途径.
- 种群遗传学方法研究等离子体的共发生和传播.
主要成果:
- 有证据表明,pbla是由Neisseria gonorrhoeae从Haemophilus ducreyi获得的.
- 结合性等离子体pConj促进了pbla的传播和共同选择,促进了它们的联合流行.
- 进化变化,包括减轻健身成本和TEMβ-乳酸酶 (如TEM-135) 的出现,提高了pbla的成功和抵抗能力.
结论:
- 普拉的演变凸显了等离子体介导的AMR对尼塞利亚淋病治疗和预防的重大威胁.
- 潜在地由Doxy-PEP加速的pbla和pConj的共同进化和传播可能会导致对第三代头素有耐药性的菌株,以及等离子体介导的扩展光谱β-乳酸酶 (ESBLs) 的出现.
- 这对公共卫生构成重大风险,需要采取紧急策略来打击球菌AMR.
相关概念视频
00:57Antibiotic Selection
52.0K
Overview
52.0K
00:46Genomic DNA in Prokaryotes
43.2K
The genome of most prokaryotic organisms consists of double-stranded DNA organized into one circular chromosome in a region of cytoplasm called the nucleoid. The chromosome is tightly wound, or supercoiled, for efficient storage. Prokaryotes also contain other circular pieces of DNA called plasmids. These plasmids are smaller than the chromosome and often carry genes that confer adaptive functions, such as antibiotic resistance.
Genomic Diversity in Bacteria
Although bacterial genomes are much...
Genomic Diversity in Bacteria
Although bacterial genomes are much...
43.2K
01:30Bacterial Signaling
31.0K
Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
31.0K